Camilla Ajassa

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia

Maria Antonella Zingaropoli, Parni Nijhawan, Anna Carraro et al. · Frontiers in Immunology · 2021 · 225 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience

Matteo Bassetti, Nadia Castaldo, Anna Maria Cattelan et al. · International Journal of Antimicrobial Agents · 2018 · 161 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +8

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri et al. · Cardiovascular Diabetology · 2020 · 114 citations · Full text

Medicine, Internal Medicine, Critical Care Cardiology +11

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)

Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe et al. · Open Forum Infectious Diseases · 2020 · 68 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +17

Influence of previous tuberculin skin test on serial IFN-γ release assays

Ilaria Sauzullo, Anna Paola Massetti, Fabio Mengoni et al. · Tuberculosis · 2011 · 32 citations

Life Sciences, Dermatology, Immunology +6